Trametinib (DMSO solvate), CAS [[1187431-43-1]]
Artikelnummer:
BYT-ORB1301426
- Bilder (1)
| Artikelname: | Trametinib (DMSO solvate), CAS [[1187431-43-1]] |
| Artikelnummer: | BYT-ORB1301426 |
| Hersteller Artikelnummer: | orb1301426 |
| Alternativnummer: | BYT-ORB1301426-10, BYT-ORB1301426-50, BYT-ORB1301426-25, BYT-ORB1301426-100, BYT-ORB1301426-200 |
| Hersteller: | Biorbyt |
| Kategorie: | Biochemikalien |
| Alternative Synonym: | type, Trametinib, Trametinib (DMSO solvate), Trametinib dimethyl sulfoxide, Trametinib DMSO solvate, JTP74057, JTP-74057, JTP-74057 (DMSO solvate), JTP 74057, inhibit, Mitogen-activated protein kinase kinase, orally, Inhibitor, MEK1/2, MEK, MAPKK, MAP2K, GSK 1120212, GSK1120212, GSK-1120212, GSK-1120212 (DMSO solvate), AIA, Adjuvant-induced, arthritis, Apoptosis, CIA, collageninduced, DMSO solvate |
| Trametinib (DMSO solvate), also known as GSK1120212, is a highly potent and selective allosteric inhibitor of MEK1 and MEK2 kinases with an IC50 of 2 nM. It is widely used in both in vitro and in vivo cancer research, particularly for studying the MAPK/ERK pathway in melanoma, NSCLC, and other malignancies. |
| Molekulargewicht: | 693.53 |
| Reinheit: | >99.99% (May vary between batches) |
| CAS Nummer: | [1187431-43-1] |
| Formel: | C28H29FIN5O5S |
| Target-Kategorie: | MEK,Apoptosis |
| Anwendungsbeschreibung: | Solubility: DMSO:1.3 mg/mL (1.87 mM),10% DMSO+40% PEG300+5% Tween 80+45% Saline:1 mg/mL (1.44 mM) |
|
|
Chemical structure of Trametinib (DMSO solvate) |
Produktgarantie und fachkundiger Support
